Theradiag a announced the success of the takeover bid initiated by Biosynex, targeting the shares of the company. In total, on the basis of a capital composed of 13,118,227 shares representing at most 13,174,282 voting rights, Biosynex will hold on the date of settlement-delivery to take place on 31…
©2023 Boursier.com